Fujian Haixi Pharmaceuticals Co., Ltd. (HKG:2637)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
237.60
+24.60 (11.55%)
At close: Apr 24, 2026

HKG:2637 Ratios and Metrics

Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Apr '26 Dec '25 Dec '24 Dec '23 Dec '22
16,76510,704---
Enterprise Value
15,40710,420---
Last Close Price
213.00136.00---
PE Ratio
75.1554.34---
PS Ratio
25.8716.52---
PB Ratio
9.456.04---
P/TBV Ratio
9.456.04---
EV/Sales Ratio
23.7716.08---
EV/EBITDA Ratio
70.9347.97---
EV/EBIT Ratio
72.0148.70---
Debt / Equity Ratio
0.070.070.110.120.32
Debt / EBITDA Ratio
0.560.560.410.401.11
Debt / FCF Ratio
---0.571.12
Net Debt / Equity Ratio
-0.77-0.77-0.40-0.55-0.76
Net Debt / EBITDA Ratio
-6.25-6.25-1.59-1.83-2.67
Net Debt / FCF Ratio
--14.80-2.54-2.67
Asset Turnover
0.450.450.710.65-
Inventory Turnover
2.122.122.641.99-
Quick Ratio
6.066.061.712.643.57
Current Ratio
6.316.311.902.853.89
Return on Equity (ROE)
16.58%16.58%28.75%33.90%-
Return on Assets (ROA)
9.23%9.23%12.62%15.30%-
Return on Invested Capital (ROIC)
49.21%49.21%48.05%85.60%110.84%
Return on Capital Employed (ROCE)
11.90%11.90%23.20%27.10%24.30%
Earnings Yield
1.18%1.84%---
Buyback Yield / Dilution
--3.42%--4.57%-
Source: S&P Global Market Intelligence. Standard template. Financial Sources.